These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11199931)

  • 1. Drug transporters revisited.
    von Moltke LL; Greenblatt DJ
    J Clin Psychopharmacol; 2001 Feb; 21(1):1-3. PubMed ID: 11199931
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential roles of P-gp and calcium channels in loperamide and diphenoxylate transport.
    Crowe A; Wong P
    Toxicol Appl Pharmacol; 2003 Nov; 193(1):127-37. PubMed ID: 14613723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of morphine, fentanyl, sufentanil, alfentanil, and loperamide with the efflux drug transporter P-glycoprotein.
    Wandel C; Kim R; Wood M; Wood A
    Anesthesiology; 2002 Apr; 96(4):913-20. PubMed ID: 11964599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining PET biodistribution and equilibrium dialysis assays to assess the free brain concentration and BBB transport of CNS drugs.
    Gunn RN; Summerfield SG; Salinas CA; Read KD; Guo Q; Searle GE; Parker CA; Jeffrey P; Laruelle M
    J Cereb Blood Flow Metab; 2012 May; 32(5):874-83. PubMed ID: 22274741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Itraconazole, gemfibrozil and their combination markedly raise the plasma concentrations of loperamide.
    Niemi M; Tornio A; Pasanen MK; Fredrikson H; Neuvonen PJ; Backman JT
    Eur J Clin Pharmacol; 2006 Jun; 62(6):463-72. PubMed ID: 16758263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for an active transport of morphine-6-beta-d-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier.
    Bourasset F; Cisternino S; Temsamani J; Scherrmann JM
    J Neurochem; 2003 Sep; 86(6):1564-7. PubMed ID: 12950465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of HM30181, a P-glycoprotein inhibitor, on the pharmacokinetics and pharmacodynamics of loperamide in healthy volunteers.
    Kim TE; Lee H; Lim KS; Lee S; Yoon SH; Park KM; Han H; Shin SG; Jang IJ; Yu KS; Cho JY
    Br J Clin Pharmacol; 2014 Sep; 78(3):556-64. PubMed ID: 24602137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of mass of [11C]-laniquidar and [11C]-N-desmethyl-loperamide on P-glycoprotein blockage at the blood-brain barrier.
    Moerman L; Dumolyn C; Boon P; De Vos F
    Nucl Med Biol; 2012 Jan; 39(1):121-5. PubMed ID: 21958857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective analysis of P-glycoprotein-mediated drug-drug interactions at the blood-brain barrier in humans.
    Sugimoto H; Hirabayashi H; Amano N; Moriwaki T
    Drug Metab Dispos; 2013 Apr; 41(4):683-8. PubMed ID: 23340958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retina Compatible Interactions and Effective Modulation of Blood Ocular Barrier P-gp Activity by Third-Generation Inhibitors Improve the Ocular Penetration of Loperamide.
    Janga KY; Tatke A; Shukla S; Lamichhane SP; Avula B; Wang X; Jablonski MM; Khan IA; Majumdar S
    J Pharm Sci; 2018 Aug; 107(8):2128-2135. PubMed ID: 29678592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Loperamide abuse - constipation or heart attack?].
    Gunnarsdottir AK; Johannsson M; Haraldsson M; Bjarnadottir GD
    Laeknabladid; 2018 Dec; 104(12):543-548. PubMed ID: 30511645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No effect of MDR1 C3435T variant on loperamide disposition and central nervous system effects.
    Pauli-Magnus C; Feiner J; Brett C; Lin E; Kroetz DL
    Clin Pharmacol Ther; 2003 Nov; 74(5):487-98. PubMed ID: 14586389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers.
    Batrakova EV; Li S; Miller DW; Kabanov AV
    Pharm Res; 1999 Sep; 16(9):1366-72. PubMed ID: 10496651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efavirenz does not interact with the ABCB1 transporter at the blood-brain barrier.
    Dirson G; Fernandez C; Hindlet P; Roux F; German-Fattal M; Gimenez F; Farinotti R
    Pharm Res; 2006 Jul; 23(7):1525-32. PubMed ID: 16779703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using PET studies of P-gp function to elucidate mechanisms underlying the disposition of drugs.
    Syvänen S; Hammarlund-Udenaes M
    Curr Top Med Chem; 2010; 10(17):1799-809. PubMed ID: 20645912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET Studies on P-glycoprotein function in the blood-brain barrier: how it affects uptake and binding of drugs within the CNS.
    Elsinga PH; Hendrikse NH; Bart J; Vaalburg W; van Waarde A
    Curr Pharm Des; 2004; 10(13):1493-503. PubMed ID: 15134571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging the impact of cyclosporin A and dipyridamole on P-glycoprotein (ABCB1) function at the blood-brain barrier: A [(11)C]-N-desmethyl-loperamide PET study in nonhuman primates.
    Damont A; Goutal S; Auvity S; Valette H; Kuhnast B; Saba W; Tournier N
    Eur J Pharm Sci; 2016 Aug; 91():98-104. PubMed ID: 27283486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relevance of assessment of intestinal P-gp inhibition using digoxin as an in vivo probe substrate.
    Shi JG; Zhang Y; Yeleswaram S
    Nat Rev Drug Discov; 2011 Jan; 10(1):75; author reply 75. PubMed ID: 21193869
    [No Abstract]   [Full Text] [Related]  

  • 19. Carbon-11 labeled tracers for in vivo imaging P-glycoprotein function: kinetics, advantages and disadvantages.
    Luurtsema G; Verbeek GL; Lubberink M; Lammertsma AA; Dierckx R; Elsinga P; Windhorst AD; van Waarde A
    Curr Top Med Chem; 2010; 10(17):1820-33. PubMed ID: 20645915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mass spectrometry imaging approach for investigating how drug-drug interactions influence drug blood-brain barrier permeability.
    Vallianatou T; Strittmatter N; Nilsson A; Shariatgorji M; Hamm G; Pereira M; Källback P; Svenningsson P; Karlgren M; Goodwin RJA; Andrén PE
    Neuroimage; 2018 May; 172():808-816. PubMed ID: 29329980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.